1-6 of 6
Marta Cesca
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3377: Bevacizumab-improved distribution of paclitaxel in ovarian cancer xenografts potentiates antitumor efficacy

Marta Cesca, Lavinia Morosi, Alexander Berndt, Ilaria Fuso Nerini, Alessandra Decio, Massimo Zucchetti, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3377.
https://doi.org/10.1158/1538-7445.AM2016-3377
Published: 15 July 2016
View article titled, Abstract 3377: Bevacizumab-improved distribution of paclitaxel in ovarian cancer xenografts potentiates antitumor efficacy
Journal Articles

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

Francesca Ricci, Francesca Bizzaro, Marta Cesca, Federica Guffanti, Monica Ganzinelli, Alessandra Decio, Carmen Ghilardi, Patrizia Perego, Robert Fruscio, Alessandro Buda, Rodolfo Milani, Paola Ostano, Giovanna Chiorino, Maria Rosa Bani, Giovanna Damia, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6980–6990.
https://doi.org/10.1158/0008-5472.CAN-14-0274
Published: 30 November 2014
View article titled, Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Open the PDF for Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations in another window
Includes: Supplementary data
Journal Articles

Abstract 2994: Cediranib affects tumor progression and survival of mice bearing patient derived ovarian carcinoma xenografts (EOC-PDX)

Alessandra Decio, Marta Cesca, Francesca Bizzaro, Dorina Belotti, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2994.
https://doi.org/10.1158/1538-7445.AM2014-2994
Published: 01 October 2014
View article titled, Abstract 2994: Cediranib affects tumor progression and survival of mice bearing patient derived ovarian carcinoma xenografts (EOC-PDX)
Journal Articles

Abstract 5096: Heterogeneous response to antiangiogenic therapy in ovarian cancer xenografts: a tool to investigate biomarkers of resistance.

Alessandra Decio, Marta Cesca, Francesca Bizzaro, Valentina Scarlato, Carmen Ghilardi, Maria Rosa Bani, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5096.
https://doi.org/10.1158/1538-7445.AM2013-5096
Published: 15 April 2013
View article titled, Abstract 5096: Heterogeneous response to antiangiogenic therapy in ovarian cancer xenografts: a tool to investigate biomarkers of resistance.
Journal Articles

A Proteomic Approach for the Identification of Vascular Markers of Liver Metastasis

Beatrice Borgia, Christoph Roesli, Tim Fugmann, Christoph Schliemann, Marta Cesca, Dario Neri, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2010) 70 (1): 309–318.
https://doi.org/10.1158/0008-5472.CAN-09-2939
Published: 04 January 2010
View article titled, A Proteomic Approach for the Identification of Vascular Markers of Liver Metastasis
Open the PDF for A Proteomic Approach for the Identification of Vascular Markers of Liver Metastasis in another window
Includes: Supplementary data
Journal Articles

The effect of vandetanib on tumor vasculature remodeling and paclitaxel uptake in a xenograft model of ovarian carcinoma

Marta Cesca, Roberta Frapolli, Ezia Bello, Alexander Berndt, Petra Richter, Anderson Ryan, Raffella Giavazzi
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4762.
Published: 01 May 2008
View article titled, The effect of vandetanib on tumor vasculature remodeling and paclitaxel uptake in a xenograft model of ovarian carcinoma